Creative Biolabs is accelerating CAR‑T innovation, driving breakthroughs in solid tumor targeting. SHIRLEY, NY, UNITED ...
Doctors at Boston’s Beth Israel share how CAR T cell therapy and other emerging immune therapies are delivering promising ...
Jefferson Health oncologist Jennifer Johnson had exhausted all the standard treatment options for her 49-year-old patient ...
Mary Bird Perkins Cancer Center has become the first facility in the region to offer a new blood cancer treatment in an outpatient setting, allowing patients to receive care while staying at home.
Within this global landscape, the EXO 001 targeted exosome platform--developed jointly by CMUH and Ever Supreme Bio Technology--stands out for its use of high-biocompatibility, naturally derived ...
H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of approved ...
The next chapter in hematology is being written at City of Hope. For patients navigating blood cancers like leukemia, lymphoma or multiple myeloma, having access to specialized experts and the most ...
A shift toward personalized treatments and programmable cell therapies opens new doors for scientists engineering T cell-based treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results